Condition: Multiple Myeloma · Sponsor: National Cancer Institute (NCI)
This randomized phase III trial studies melphalan and prednisone with thalidomide to see how well it works compared to melphalan and prednisone together with lenalidomide in treating patients with newly diagnosed multiple myeloma. Drugs used in chemotherapy, such as melphalan and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Thalidomide and lenalidomide may stop the growth of multiple myeloma by blocking blood flow to the cancer. It is not yet known whether melphalan and prednisone are more effective when given together with thalidomide or lenalidomide in treating multiple myeloma.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Providence Hospital | Mobile, Alabama, United States | — |
| Mayo Clinic in Arizona | Scottsdale, Arizona, United States | — |
| Sparks Regional Medical Center | Fort Smith, Arkansas, United States | — |
| UC San Diego Moores Cancer Center | La Jolla, California, United States | — |
| Fremont - Rideout Cancer Center | Marysville, California, United States | — |
| Memorial Medical Center | Modesto, California, United States | — |
| University of California Davis Comprehensive Cancer Center | Sacramento, California, United States | — |
| UC San Diego Medical Center - Hillcrest | San Diego, California, United States | — |
| Kaiser Permanente-San Diego Mission | San Diego, California, United States | — |
| San Diego VA Medical Center | San Diego, California, United States | — |
| Gene Upshaw Memorial Tahoe Forest Cancer Center | Truckee, California, United States | — |
| The Medical Center of Aurora | Aurora, Colorado, United States | — |
+ 379 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.